NEW YORK (360Dx) – A lot of people who think heart burn is not an issue don't recognize that it could progress to cancer.

For Cernostics, raising awareness of this health threat could be the catalyst to increase sales of its TissueCypher Barrett's Esophagus test, the firm's CEO Michael Hoerres said in an interview.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.